Cargando…
A molecular signature for the prediction of recurrence in colorectal cancer
BACKGROUND: Several clinical and pathological factors have an impact on the prognosis of colorectal cancer (CRC), but they are not yet adequate for risk assessment. We aimed to identify a molecular signature that can reliably identify CRC patients at high risk for recurrence. RESULTS: Two hundred ei...
Autores principales: | Wang, Lisha, Shen, Xiaohan, Wang, Zhimin, Xiao, Xiuying, Wei, Ping, Wang, Qifeng, Ren, Fei, Wang, Yiqin, Liu, Zebing, Sheng, Weiqi, Huang, Wei, Zhou, Xiaoyan, Du, Xiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320628/ https://www.ncbi.nlm.nih.gov/pubmed/25645394 http://dx.doi.org/10.1186/s12943-015-0296-2 |
Ejemplares similares
-
Role of MUC20 overexpression as a predictor of recurrence and poor outcome in colorectal cancer
por: Xiao, Xiuying, et al.
Publicado: (2013) -
Abnormal expression of GADD45B in human colorectal carcinoma
por: Wang, Lisha, et al.
Publicado: (2012) -
Plasma miR-601 and miR-760 Are Novel Biomarkers for the Early Detection of Colorectal Cancer
por: Wang, Qifeng, et al.
Publicado: (2012) -
Abnormal expression of CDK11(p58) in prostate cancer
por: Chi, Yayun, et al.
Publicado: (2014) -
Stomatin-like Protein 2 Promotes Tumor Cell Survival by Activating the JAK2-STAT3-PIM1 Pathway, Suggesting a Novel Therapy in CRC
por: Liu, Qiang, et al.
Publicado: (2020)